Mallinckrodt
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Mallinckrodt sits in the top decile of US sponsors by registered trial count (#307 of 15,742 sponsors by registered trial count).
Mallinckrodt: 69 sponsored US clinical trials, none currently recruiting.
Mallinckrodt sponsors 69 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 52 completed. 34 of these trials are in Phase 3-4 (later-stage) and 31 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Keratitis, with 1 trials.
Top-decile sponsor footprint
Mallinckrodt ranks in the top decile of sponsors by registered trial count (#307 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
52 of 69 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (75.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
69 total, page 2 of 2
Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Crohn's Disease
NCT00221026
Nitric Oxide Inhalation to Treat Sickle Cell Pain Crises
NCT00094887
Comparison of Inhaled Nitric Oxide and Oxygen in Participants Reactivity During Acute Pulmonary Vasodilator Testing
NCT00626028
Safety and Tolerability of Inhaled Nitric Oxide in Patients With Cystic Fibrosis
NCT00570349
Study of Terlipressin Versus Placebo to Treat Hepatorenal Syndrome Type 1
NCT00089570
Fed Study of Chlorpheniramine Polistirex and Hydrocodone Polistirex Capsules and Tussionex® Pennkinetic® Extended Release Oral Suspension
NCT00853190
Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Rheumatoid Arthritis
NCT00221000
The Effects of Nitric Oxide for Inhalation During Left Ventricular Assists Device (LVAD) Implantation
NCT00060840
Study to Evaluate the Effect of Age (Geriatric) and Kidney Function on the Safety, Efficacy and Pharmacokinetics of OctreoScan in Patients Who Have New or Recurrent Tumors
NCT00944372
Fed Study of Oxycodone Hydrochloride 30 mg Tablets and Roxicodone™ 30 mg Tablets
NCT00853736
Fasting Study of Oxycodone Hydrochloride 15 mg Tablets and Roxicodone™ 15 mg Tablets
NCT00853320
Fasting Study of Oxycodone Hydrochloride 30 mg Tablets and Roxicodone™ 30 mg Tablets
NCT00853216
Fasting Study of Hydromorphone Hydrochloride 8 mg Tablets and Dilaudid 8 mg Tablets
NCT00853554
Safety and Efficacy Study of Photopheresis Plus Standard Therapy to Treat Chronic Graft-versus-Host Disease
NCT00054613
Safety and Efficacy Study of Photopheresis With UVADEX to Prevent Graft-versus-Host Disease
NCT00054600
Inhaled Nitric Oxide in Neonates With Elevated A-a DO2 Gradients Not Requiring Mechanical Ventilation
NCT00041548
Hospital-Based Program for Treatment of Severe Cardiopulmonary Disease With Inhaled Nitric Oxide
NCT00041574
Effects of Inhaled Nitric Oxide in the Treatment of Acute Hypoxemic Respiratory Failure (AHRF) in Pediatrics
NCT00041561
Inhaled Nitric Oxide in Prevention/Treatment of Ischemia-Reperfusion Lung Injury Related to Lung Transplantation
NCT00060450
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 16 |
| Phase 2 | 15 |
| Phase 3 | 22 |
| Phase 4 | 12 |
How the Mallinckrodt archive is shaped
69 indexed studies, none listed as recruiting (0% open); 52 completed (75%).
Phase mix: 34 late (III/IV) vs 31 early (I/II) (balanced across stages).
Top condition: Keratitis (1 trial), 9 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Mallinckrodt: archived-pipeline peers nationwide
Peers matched on 69 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Mallinckrodt sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 69 archived trials
- Providence Health & Services · 69 trials · 7% recruiting
- Texas Tech University · 69 trials · 17% recruiting
- University of Colorado, Boulder · 69 trials · 22% recruiting
- Procter and Gamble · 70 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Mallinckrodt page
69 registered trials is a research-attention snapshot, not an endorsement of Mallinckrodt or any single study.
- None of Mallinckrodt's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Keratitis is the condition Mallinckrodt studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Keratitis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Mallinckrodt pipeline card: 69 registered trials from official public datasets.Report a data error.